Enlivex Therapeutics Ltd.
ENLV
$1.05
-$0.05-4.55%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -14.00% | -19.65% | -10.24% | -34.86% | -45.63% |
Total Receivables | 517.90% | -- | -- | -- | -64.61% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -20.14% | -20.41% | -35.57% | -39.91% | -23.07% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -96.12% | 101.77% | 101.77% | 202.65% | -- |
Total Current Assets | -23.02% | -14.86% | -7.20% | -24.49% | -35.48% |
|
|||||
Total Current Assets | -23.02% | -14.86% | -7.20% | -24.49% | -35.48% |
Net Property, Plant & Equipment | -55.31% | -87.61% | -85.83% | -84.84% | -82.68% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 11.09% | 14.95% | 68.04% | 7.79% | 18.20% |
Total Assets | -24.83% | -36.52% | -39.84% | -48.27% | -45.55% |
|
|||||
Total Accounts Payable | -1.93% | -88.41% | -80.50% | -56.64% | -57.55% |
Total Accrued Expenses | -28.56% | -17.26% | -20.51% | -20.16% | -8.76% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -32.08% | -50.64% | -49.63% | -50.00% | -47.01% |
Total Finance Division Other Current Liabilities | -88.48% | -- | -- | -- | -- |
Total Other Current Liabilities | -88.48% | -- | -- | -- | -- |
Total Current Liabilities | -37.32% | -35.68% | -43.08% | -33.82% | -8.26% |
|
|||||
Total Current Liabilities | -37.32% | -35.68% | -43.08% | -33.82% | -8.26% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -56.41% | -89.03% | -86.52% | -85.31% | -83.64% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -39.26% | -60.65% | -61.58% | -55.59% | -37.53% |
|
|||||
Common Stock & APIC | 6.04% | 4.79% | 4.65% | 1.62% | 1.67% |
Retained Earnings | -13.39% | -18.38% | -22.98% | -28.80% | -35.01% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | -21.59% | -31.44% | -35.58% | -46.91% | -47.07% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -21.59% | -31.44% | -35.58% | -46.91% | -47.07% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -21.59% | -31.44% | -35.58% | -46.91% | -47.07% |
|